WDFY3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.167400E-01
Normal-vs-Stage2
4.815200E-01
Normal-vs-Stage3
2.144400E-01
Normal-vs-Stage4
9.700800E-01
Stage1-vs-Stage2
6.484200E-02
Stage1-vs-Stage3
1.282110E-02
Stage1-vs-Stage4
6.520800E-01
Stage2-vs-Stage3
1.62857999999044E-05
Stage2-vs-Stage4
3.811800E-01
Stage3-vs-Stage4
1.711600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.477800E-01
Normal-vs-AfricanAmerican
9.985400E-01
Normal-vs-Asian
3.537800E-01
Caucasian-vs-AfricanAmerican
5.211600E-01
Caucasian-vs-Asian
3.718400E-01
AfricanAmerican-vs-Asian
2.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.446800E-01
Normal-vs-Female
6.848400E-01
Male-vs-Female
6.006200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.065400E-01
Normal-vs-Age(41-60Yrs)
9.485000E-01
Normal-vs-Age(61-80Yrs)
5.210200E-01
Normal-vs-Age(81-100Yrs)
1.694170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.001800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.802000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.805600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.226270E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.251500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.662200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.909600E-01
Normal-vs-Daily Drinker
3.241200E-01
Normal-vs-Weekly Drinker
1.957050E-01
Normal-vs-Occasional Drinker
9.474400E-01
Normal-vs-Social Drinker
9.856800E-01
Non Drinker-vs-Daily Drinker
9.056200E-01
Non Drinker-vs-Weekly Drinker
8.874200E-01
Non Drinker-vs-Occasional Drinker
6.143900E-02
Non Drinker-vs-Social Drinker
1.892370E-01
Daily Drinker-vs-Weekly Drinker
8.068600E-01
Daily Drinker-vs-Occasional Drinker
9.751500E-02
Daily Drinker-vs-Social Drinker
2.220600E-01
Weekly Drinker-vs-Occasional Drinker
7.642300E-02
Weekly Drinker-vs-Social Drinker
1.680760E-01
Occasional Drinker-vs-Social Drinker
9.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.383220E-01
Normal-vs-Grade 2
2.394100E-02
Normal-vs-Grade 3
1.752060E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.500200E-01
Grade 1-vs-Grade 3
5.312000E-01
Grade 1-vs-Grade 4
1.383220E-01
Grade 2-vs-Grade 3
3.176600E-01
Grade 2-vs-Grade 4
2.394100E-02
Grade 3-vs-Grade 4
1.752060E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.661200E-01
Normal-vs-NonDiabetic
6.797800E-01
Diabetic-vs-NonDiabetic
1.145810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.574400E-01
Normal-vs-NoPancreatitis
6.036200E-01
Pancreatitis-vs-NoPancreatitis
3.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.269800E-01
Normal-vs-N1
5.361400E-01
N0-vs-N1
5.019200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.939400E-01
Normal-vs-TP53-NonMutant
9.947000E-01
TP53-Mutant-vs-TP53-NonMutant
1.798560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
